Results 121 to 130 of about 73,450 (306)

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec   +6 more
wiley   +1 more source

F^ω-injectors of finite groups [PDF]

open access: yesИзвестия Саратовского университета. Новая серия: Математика. Механика. Информатика
Only finite groups and classes of finite groups are considered. $\frak F$-injectors (B. Fischer, W. Gaschutz, B. Hartley, 1967) and $\frak F$-projectors (W.
Sorokina, Marina M., Novikova, Diana G.
doaj   +1 more source

Comprehensive Assessment of Arterial, Tissue, and Venous Collaterals for Evaluating the Infarct Growth Rate: The Multimodal Collateral Score

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto   +12 more
wiley   +1 more source

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi   +9 more
wiley   +1 more source

On a maximal subgroup of the affine general linear group of GL(6, 2) [PDF]

open access: yesAdvances in Group Theory and Applications, 2021
Ayoub B.M. Basheer, Jamshid Moori
doaj   +1 more source

Coprime invariable generation and minimal-exponent groups

open access: yes, 2015
Colva Roney-Dougal acknowledges the support of EPSRC grant EP/I03582X/1.A finite group G is coprimely invariably generated if there exists a set of generators {g1,. .,gu} of G with the property that the orders |g1|,.
Lucchini, Andrea   +4 more
core   +1 more source

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuralgic amyotrophy (NA) is a prevalent, monophasic, multifocal immune‐mediated neuropathy. A distinctive characteristic of the disease is the occurrence of nerve or fascicle constrictions and torsions (NA‐associated focal nerve lesions, NAFL). The pathophysiology underlying this phenomenon remains to be fully elucidated.
Johannes Fabian Holle   +4 more
wiley   +1 more source

The Fischer-Clifford matrices of the inertia group 2^7:O-(6,2) of a maximal subgroup 2^7:SP(6,2) in SP(8,2) [PDF]

open access: yesInternational Journal of Group Theory, 2013
The subgroups of symplectic groups which fix a non-zero vector of the underlying symplectic space are called affine subgroups. The split extension group A(4) = 2^7:SP(6,2) is the affine subgroup of the symplectic group SP(8,2) of index 255. In this paper,
Richard Llewellyn Fray   +1 more
doaj  

Base sizes for sporadic simple groups

open access: yes, 2010
Let G be a permutation group acting on a set . A subset of is a base for G ifits pointwise stabilizer in G is trivial. We write b(G) for the minimal size of a base forG.
Robert A. Wilson   +8 more
core   +1 more source

Impact of Plasma p‐tau181 on Cognition, Motor Phenotypes, and Disease Course in ALS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Phosphorylated tau181 (p‐tau181), an Alzheimer's disease biomarker, was recently evaluated in amyotrophic lateral sclerosis (ALS). We investigated plasma p‐tau181 in 202 ALS/ALS‐FTD patients and 94 healthy controls, assessing cognitive performance, motor function, and longitudinal dynamics.
Elisabeth Kasper   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy